DermBiont

Boston, United States

DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.

$35.2M raised

Oct 2023

Series B

Top Investors

Civilization VenturesViking Global InvestorsValia VenturesJoyance PartnersToba Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has DermBiont raised?

DermBiont has raised $35.2M in total funding. The most recent round was Series B. The last funding was announced in October 2023.

Who are DermBiont's investors?

DermBiont's investors include Civilization Ventures, Viking Global Investors, Valia Ventures, Joyance Partners, Toba Capital.

Where is DermBiont headquartered?

DermBiont is headquartered in Boston, United States.

What does DermBiont do?

DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.

What stage is DermBiont at?

DermBiont is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 19, 2023.

MLA

"DermBiont — Funding & Investors." VCBacked, October 19, 2023, https://www.vcbacked.co/company/dermbiont. Accessed June 12, 2026.

APA

VCBacked. (2023). DermBiont — Funding & Investors. Retrieved June 12, 2026, from https://www.vcbacked.co/company/dermbiont

Wikipedia (cite web)

{{cite web |title=DermBiont — Funding & Investors |url=https://www.vcbacked.co/company/dermbiont |website=VCBacked |access-date=June 12, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 19, 2023.